A comprehensive, modular Python automation system for HEC-RAS flood analysis workflows. This professional-grade tool demonstrates advanced hydraulic modeling capabilities, Python integration, and ...

A U.S. Navy Global Autonomous Reconnaissance Craft (GARC) maneuvers in the Atlantic Ocean on Sept. 23, 2025, during UNITAS 2025, the 66th iteration of the world’s longest-running multinational ...

Binder has introduced the Harsh Environment Connector (HEC) that is engineered for reliable performance in demanding outdoor applications. With robust materials, advanced sealing technology, and a ...

A blue protein ribbon structure labeled PI3Kα has a space-filling molecule bound to it, which interacts (clashes) with a second protein ribbon molecule labeled KRas. This model shows how BBO-10203 ...

OpenAI has acquired Software Applications Incorporated, a small but promising startup founded by former Apple engineers. The acquisition of the company, best known for creating the natural language ...

For the first time in four years, the federal government plans to begin processing first-time applications for Deferred Action for Childhood Arrivals (DACA). The program gives deportation protection ...

As freshmen settle in for their first year of college, their arrival on campuses marks a milestone higher education has long dreaded: this incoming class is the last big one before a prolonged ...

BEIJING/HONG KONG, Sept 10 (Reuters) - U.S. investment firm Bain Capital has agreed to sell data centre operator WinTriX DC Group's China business to a consortium led by Guangdong Hec Technology ...

Lower mortgage rates prompted mortgage applications to increase 9.2% from one week earlier, according to data from the Mortgage Bankers Association (MBA)’s weekly mortgage applications survey for the ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.